Reference Citation Analysis: Find an Article, Find a Category, Find a Journal, Find a Scholar

For: Chen J, Ma L, Huang L, Xie C, Pei H, He L, Fu S, Chen L. Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease. Chem Biol Drug Des 2014;86:66-79. [PMID: 25215862 DOI: 10.1111/cbdd.12429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2014] [Revised: 08/27/2014] [Accepted: 09/05/2014] [Indexed: 02/05/2023]

For:	Chen J, Ma L, Huang L, Xie C, Pei H, He L, Fu S, Chen L. Discovery of a Potent 9-Deazaxanthine-based Agent for the Treatment of Obesity-Related Non-alcoholic Fatty Liver Disease. Chem Biol Drug Des 2014;86:66-79. [PMID: 25215862 DOI: 10.1111/cbdd.12429] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/18/2014] [Revised: 08/27/2014] [Accepted: 09/05/2014] [Indexed: 02/05/2023]

Number

Cited by Other Article(s)

Pei H, Xie C, Liu Y, Shao M, Chen J, Li D, Ma L, Chen L. Therapeutic potential of a synthetic FABP4 inhibitor 8g on atherosclerosis in ApoE-deficient mice: the inhibition of lipid accumulation and inflammation. RSC Adv 2016. [DOI: 10.1039/c6ra05637g] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/05/2023] Open